A randomized double blind placebo controlled study on the effects of fenretinide Lym-X-Sorb on insulin sensitivity in obese insulin resistant subjects.

Academic Medical Center (AMC)0 sites20 target enrollmentTBD

ConditionsObesityMetabolic syndrome XInsulin resistanceFatty liver

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: ObesityMetabolic syndrome XInsulin resistanceFatty liver
Sponsor: Academic Medical Center (AMC)
Enrollment: 20
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

Academic Medical Center (AMC)

Eligibility Criteria

Inclusion Criteria

•1\. Post menopausal female;
•2\. Age 40\-65 years;

Exclusion Criteria

•1\. T2DM treated with medication other than metformin or sulfonylurea derivates;
•2\. Any medical condition except for glucose intolerance, T2DM, hypertension and secondary dyslipidemia;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

Not Applicable

Alfentanil in CT-colonography.PainCt-colonographyColorectal cancerPolyps

NL-OMON25320Academic Medical Center90

Completed

Not Applicable

Efficacy and safety of ezetimibe in young children with familial hypercholesterolemia.Familial hypercholesterolemia

NL-OMON25426Academic Medical Centre (AMC), Department of Vascular Medicine70

Recruiting

Not Applicable

Magnesium oxide to reduce prostate motion.1. Prostate cancer<br />2. radiotherapy.<br />(NLD: prostaatkanker, bestraling).

NL-OMON24191niversity Medical Center Utrecht, The Netherlands184

Completed

Not Applicable

Randomized, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischemia.Refractory angina pectoris and documented myocardial ischemia.

NL-OMON29227Departmartement of Cardiology,Leiden University Medical Center ,Leiden, the Netherlands50

Recruiting

Not Applicable

A Randomized placebo controlled double blind clinical trial comparing selenium and pentoxifylline in patients with mild Graves' orbitopathy. EUGOGO study BMild Graves' orbitopathy

NL-OMON24865Prof. dr. W.M. WiersingaDept. of Endocrinology and MetabolismAcademic Medical CenterMeibergdreef 91105 AZ AmsterdamT: +31 20 5666071F: +31 20 6917682e-mail: w.m.wiersinga@amc.uva.nl156